3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
39
Squamous Cell Carcinoma of Head and Neck
20
Lung Neoplasms
20
Oropharyngeal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Urinary Bladder Neoplasms
7
Uterine Cervical Neoplasms
6
Endometrial Neoplasms
6
Carcinoma
6
Pancreatic Neoplasms
5
Mouth Neoplasms
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Biliary Tract Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Nasopharyngeal Carcinoma
4
Laryngeal Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Squamous Cell
4
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Triple Negative Breast Neoplasms
2
Tongue Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Salivary Gland Neoplasms
2
Rectal Neoplasms
2
Interventions
Cytarabine
5
Whole-Body Irradiation
3
Specimen Handling
3
Injections
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
fludarabine
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
selinexor
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Cisplatin
×
30 days
×
Clear all
No trials found.